DYN
DYN
NASDAQ · Biotechnology

Dyne Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$17.62
-0.92 (-4.96%)
As of Nov 5, 8:45 PM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 19 90%
Hold 1 5%
Sell 1 5%
Price Target
Analyst Price Target +455.4% upside
Low Target $76.65
Average Target $97.86
High Target $132.93
Current Price $17.62
Current
$17.62
Target
$97.86
$76.65 $97.86 avg $132.93
Scenario Analysis
Bear Case
$76.65
335.0%
Low target
Base Case
$97.86
+455.4%
Avg target
Bull Case
$132.93
+654.4%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$27.31
-35.5% from high
52-Week Low
$14.00
+25.9% from low
50-Day SMA
$18.04
-2.3% vs SMA
200-Day SMA
$19.33
-8.8% vs SMA
RSI (14)
72.2
Overbought
Target vs 52W High
$97.86
+258.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -10.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +116.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -38.1%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -60.7%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -35.8%